Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday.

Shares of Enliven Therapeutics, Inc. ELVN rose sharply during Thursday’s session.

Enliven Therapeutics announced proof of concept data from Phase 1 clinical trial of ELVN-001 in chronic myeloid leukemia.

Enliven Therapeutics shares surged 26% to $24.97 on Thursday.

Here are some other big stocks recording losses in today’s session.

• Rallybio Corporation RLYB shares gained 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.
• Alpine Immune Sciences, Inc. ALPN jumped 36.6% to $64.25 after Vertex entered into an agreement to acquire the company.
• Janux Therapeutics, Inc. JANX shares jumped 16.8% to $52.15 following Wednesday reports suggesting the company is said to weigh a possible sale.
• Gyre Therapeutics, Inc. GYRE rose 14.6% to $15.91.
• AnaptysBio, Inc. ANAB rose 11.4% to $24.72. Wells Fargo analyst Derek Archila initiated coverage on AnaptysBio with an Overweight rating and announced a price target of $56.
• Fiverr International Ltd. FVRR gained 10.5% to $21.25 after the company's board authorized a $100 million share repurchase program.
• GigaCloud Technology Inc. GCT shares jumped 10.2% to $34.18.
• Nurix Therapeutics, Inc. NRIX climbed 9.6% to $17.21. Baird analyst Joel Beatty maintained Nurix Therapeutics with an Outperform and raised the price target from $24 to $25.
• AlTi Global, Inc. ALTI gained 9.3% to $5.06.
• Nexxen International Ltd. NEXN rose 7.3% to $5.62.
• StepStone Group LP STEP gained 7.1% to $37.46 after JP Morgan upgraded the stock from Neutral to Overweight.
• Frontline plc FRO rose 5.9% to $24.47.
• IAMGOLD Corporation IAG gained 3.6% to $3.74.

Now Read This: Dell, Designer Brands And 2 Other Stocks Insiders Are Selling